New daily pill aims to stop dangerous swelling attacks
NCT ID NCT06669754
Summary
This study is testing whether a new daily pill called deucrictibant can safely prevent the sudden, painful swelling attacks caused by hereditary angioedema (HAE). About 81 adolescents and adults with HAE will take either the real pill or a placebo (a dummy pill) for 24 weeks to see if it reduces the number of attacks. The main goal is to see if the pill is effective and safe for long-term prevention.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEREDITARY ANGIOEDEMA (HAE) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Study Site
Little Rock, Arkansas, 72205, United States
-
Study Site
San Diego, California, 92122, United States
-
Study Site
Chevy Chase, Maryland, 20915, United States
-
Study Site
St Louis, Missouri, 63141, United States
-
Study Site
Corrientes, Argentina
-
Study Site
San Martín, Argentina
-
Study Site
Santo André, Brazil
-
Study Site
Sofia, 1431, Bulgaria
-
Study Site
Sofia, 1680, Bulgaria
-
Study Site
Edmonton, Canada
-
Study Site
Ottawa, Canada
-
Study Site
Grenoble, France
-
Study Site
Lille, 59037, France
-
Study Site
Berlin, Germany
-
Study Site
Frankfurt, Germany
-
Study Site
Hanover, Germany
-
Study Site
Hong Kong, Hong Kong
-
Study Site
Budapest, Hungary
-
Study Site
Dublin, Ireland
-
Study Site
Milan, 20062, Italy
-
Study Site
Padua, Italy
-
Study Site
Kawasaki, Japan
-
Study Site
Tokyo, 113-0033, Japan
-
Study Site
Tokyo, 1130033, Japan
-
Study Site
Auckland, New Zealand
-
Study Site
Krakow, Poland
-
Study Site
San Juan, Puerto Rico
-
Study Site
Sângeorgiu de Mureş, Romania
-
Study Site
Singapore, Singapore
-
Study Site
Martin, Slovakia
-
Study Site
Cape Town, South Africa
-
Study Site
Daegu, South Korea
-
Study Site
Seoul, 06351, South Korea
-
Study Site
Seoul, South Korea
-
Study Site
Suwon, South Korea
-
Study Site
Barcelona, 08013, Spain
-
Study Site
Barcelona, 08907, Spain
-
Study Site
Seville, Spain
-
Study Site
Basel, Switzerland
-
Study Site
Ankara, Turkey (Türkiye)
-
Study Site
Istanbul, Turkey (Türkiye)
-
Study Site
Izmir, Turkey (Türkiye)
-
Study Site
Birmingham, B18 7QH, United Kingdom
-
Study Site
Birmingham, B9 5SS, United Kingdom
-
Study Site
Bristol, BS10 5NB, United Kingdom
-
Study Site
Cambridge, CB2 0QQ, United Kingdom
-
Study Site
Frimley, GU16 7UJ, United Kingdom
-
Study Site
Leeds, LS9 7TF, United Kingdom
-
Study Site
London, NW3 2QG, United Kingdom
-
Study Site
Oxford, United Kingdom
-
Study Site
Southampton, United Kingdom
-
Study Site
Stoke, United Kingdom
-
Study site
Santa Monica, California, 90404, United States
-
Study site
Walnut Creek, California, 94598, United States
-
Study site
London, England, E1 1FR, United Kingdom
-
Study site
Plymouth, PL6 5FP, United Kingdom
Conditions
Explore the condition pages connected to this study.